Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Hemodynamic Response to Laryngoscopy
NCT05909215Phase 4Completed
- Sponsor
- Sindh Institute of Urology and Transplantation
- Start
- Aug 2021
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine in hemodynamic instability (3 arms), sponsored by Sindh Institute of Urology and Transplantation. Primary endpoint: Hemodynamic Response. Started Aug 2021; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
hemodynamic instability
Beyond the preview
Go deeper on NCT05909215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05909215.